Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Formation of Adipose Scar Tissue Begins with Activation of Platelet-Derived Growth Factor Receptor Alpha Signaling

By LabMedica International staff writers
Posted on 08 Jun 2015
Researchers have found a link between activation of PDGFRalpha (platelet-derived growth factor receptor alpha) signaling in perivascular cells (such as pericytes, connective tissue cells that occur about small blood vessels) and the formation of scar tissue that can lead to metabolic dysfunction and development of chronic diseases such as diabetes.

Fibrosis is a common disease process in which pro-fibrotic cells disturb organ function by secreting disorganized extracellular matrix (ECM). More...
Adipose tissue fibrosis occurs during obesity and is associated with metabolic dysfunction, but how pro-fibrotic cells originate is as yet unknown.

In this regard, investigators at Oklahoma Medical Research Foundation (Oklahoma City, USA) used a developmental model to investigate perivascular cells in white adipose tissue (WAT) and their potential to cause organ fibrosis.

They reported in the May 27, 2015, online edition of the journal Genes & Development that activation of PDGFRalpha signaling in perivascular cells caused them to transition into ECM-synthesizing pro-fibrotic cells. Before this transition occurred, PDGFRalpha signaling up-regulated mTOR (mammalian target of rapamycin) signaling and ribosome biogenesis pathways and perturbed the expression of a network of epigenetically imprinted genes that had been implicated in cell growth and tissue homeostasis.

"Scarring can be an important part of the healing process when a person suffers an injury," said senior author Dr. Lorin Olson, assistant professor of immunobiology and cancer research at Oklahoma Medical Research Foundation. "But excessive scarring, or fibrosis, can contribute to many dangerous health conditions. When fat cells are surrounded by scar tissue, it inhibits their ability to store lipids. When that happens, the lipids are stored in places like the liver or muscle. That can cause insulin resistance, which can lead to diabetes. By studying the molecular mechanisms involved in the process, we will try to understand the role it may play in heart disease, diabetes and other metabolic disorders."

Related Links:

Oklahoma Medical Research Foundation



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.